In oral cancer, Xie et al. confirmed that human bone marrow mesenchymal stem cell-derived exosomes loaded with miR-101-3p regulated MMP2 levels and inhibited migration and invasion of OSCC cells in vitro and in vivo [101], providing a new theoretical basis for treating oral cancer. This evidence concerns the gene MMP2 and lip and oral cavity carcinoma.